During GLP-1 therapy, monitoring body composition provides crucial information about the quality of your weight loss
By product, the Zepbound segment is expected to grow rapidly during the forecast period
Proponents claim these patches can suppress appetite, slow gastric emptying, and improve insulin secretioneffects associated with legitimate GLP-1 receptor agonists
Limitations: As with all GLP-1 therapies, ongoing monitoring for gastrointestinal side effects and potential hypoglycemia (especially in combination with a sulfonylurea) remains crucial
Shima Hadidchi MD Family Practice is to support patients in achieving their weight-loss objectives safely and effectively, utilizing evidence-based treatments such as GLP-1 receptor agonists, alongside personalized lifestyle counseling and ongoing clinical support
GLP-1s can also cause gastrointestinal issues such as nausea and vomiting, which may cause some people to discontinue use due to side effects before achieving their weight-loss goals